T-20 (Enfuvirtide, Fuzeon): Archive 1999-2002

DO. SEE. HEAR. KNOW. Visit TheBody.com's 2008 World AIDS Day Center >>

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

Fuzeon (T-20) Enters the Home Stretch (December 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis
T-20 May Help Expand Number of Treatable Groups (September 30, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
What's Taking T-20 So Long? (April 2001)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Fusion Inhibitors (September/October 1999)
T-20 (Pentafuside) and T-1249.
In GMHC Treatment Issues, from Gay Men's Health Crisis

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.